EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure

Nandi Bao iD, Xiaoli Liu, Xiaoling Zhong, Shuangshuang Jia, Ning Hua, Li Zhang, Guoxin Mo iD

PeerJ · 26.07.2023 · 11 · e15589

DOI: 10.7717/peerj.15589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 26.07.2023. Verfasst von Nandi Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Heart Failure, Vascular Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the potential microbiome profile of a mouse model with heart failure (HF) during dapagliflozin treatment.

Method

An HF model was constructed in 8-week-old male mice, and cardiac tissues were analyzed using histological staining. Hemodynamic indexes were measured, and fecal samples were collected for 16S rDNA sequencing. Chao1, Shannon, and Simpson were used for α-diversity analysis. b-Diversity analysis was conducted using principal coordinate analysis (PCoA) and non-metric multidimensional scaling (NMDS) based on the Bray–Curtis distance. Linear discriminant analysis coupled with effect size measurements (LEfSe) was used to identify signature gut microbiota, and phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict the function of altered gut microbiota.

Result

Dapagliflozin treatment reduced inflammation, infarction area, and cardiac fibrosis in HF mice. It also increased endothelial-dependent dilation and inflammation in mice with HF. Dapagliflozin decreased the ratio of Firmicutes/Bacteroidetes, which was increased in HF mice. There was no significant statistical difference in α-diversity among the control, HF, and HF+dapagliflozin groups. Desulfovibrio , AF12 , and Paraprevotella were enriched in HF+dapagliflozin, while Rikenella and Mucispirillum were enriched in HF based on LEfSe. KEGG analysis revealed that altered gut microbiota was associated with fermentation, amino acid biosynthesis, nucleoside and nucleotide biosynthesis/degradation, fatty acid and lipid biosynthesis, carbohydrate biosynthesis/degradation, and cofactor/prosthetic group/electron carrier/vitamin biosynthesis.

Conclusion

Understanding the microbiome profile helps elucidate the mechanism of dapagliflozin for HF. The signature genera identified in this study could be used as a convenient method to distinguish between HF patients and healthy individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeHeart FailureVascular DiseasesMaleAnimalsMicePhylogenyBacteroidetesInflammationBenzhydryl CompoundsGlucosides

Stichwörter der Autor:innen

16S rDNA sequencingDapagliflozinGut microbiotaHeart failureSGLT-2 inhibitors

Substanzen

dapagliflozinBenzhydryl CompoundsGlucosides

Autor:innen und Institutionen

  • Chinese PLA General Hospital, Beijing, China.
  • First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • South China University of Technology, Guangzhou, China.
  • Anhui Medical University, Hefei, China.
  • The Eighth Medical Center of PLA General Hospital, Beijing, China.

ORCID-Profile: Nandi Bao, Guoxin Mo

Zitieren

APA

Bao, N., Liu, X., Zhong, X., Jia, S., Hua, N., Zhang, L., & Mo, G. (2023). Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure. PeerJ, 11, e15589. https://doi.org/10.7717/peerj.15589

Vancouver

Bao N, Liu X, Zhong X, Jia S, Hua N, Zhang L, et al. Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure. PeerJ. 2023;11:e15589. doi:10.7717/peerj.15589

BibTeX
@article{Bao2023,
  author = {Bao, Nandi and Liu, Xiaoli and Zhong, Xiaoling and Jia, Shuangshuang and Hua, Ning and Zhang, Li and Mo, Guoxin},
  title = {Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure},
  journal = {PeerJ},
  year = {2023},
  volume = {11},
  pages = {e15589},
  doi = {10.7717/peerj.15589}
}
Kostenlos starten →